(Q42684786)

English

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis

scientific article published on May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 November 2017

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis (English)

1 reference

Europe PubMed Central

4 November 2017

bioavailability

1 reference

based on heuristic

inferred from title

author name string

Miner PB Jr

1

1 reference

Europe PubMed Central

4 November 2017

Geary RS

2

1 reference

Europe PubMed Central

4 November 2017

Matson J

3

1 reference

Europe PubMed Central

4 November 2017

Chuang E

4

1 reference

Europe PubMed Central

4 November 2017

Xia S

5

1 reference

Europe PubMed Central

4 November 2017

Baker BF

6

1 reference

Europe PubMed Central

4 November 2017

Wedel MK

7

1 reference

Europe PubMed Central

4 November 2017

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

4 November 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

4 November 2017

23

1 reference

Europe PubMed Central

4 November 2017

1427-1434

1 reference

Europe PubMed Central

4 November 2017

10

1 reference

Europe PubMed Central

4 November 2017

ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02909.X

21 January 2018

Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02909.X

21 January 2018

Subcellular localization of intercellular adhesion molecule-1 in colonic mucosa in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02909.X

21 January 2018

Progress in antisense technology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02909.X

21 January 2018

A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02909.X

21 January 2018

An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02909.X

21 January 2018

Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02909.X

21 January 2018

Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02909.X

21 January 2018

Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02909.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2006.02909.X

1 reference

Europe PubMed Central

4 November 2017

1 reference

Europe PubMed Central

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42684786&oldid=1965544329"